No Smoke and No Fire: The Rise of Internal Controls Absent Anti-Bribery Violations in FCPA Enforcement
From Pay-for-Delay to Product Hopping: The Limited Utility of Antitrust Law in the Pharmaceutical Industry
Informed Consent and Privacy of Non-Identified Bio-Specimens and Estimated Data: Lessons from Iceland and the United States in an Era of Computational Genomics
